Commonly Used Medications in PALS
Medication recommendations change quickly. It is highly recommended that a pharmacist be included on the resuscitation team to manage all drugs and dosages for pediatric patients.
Drug |
Classification |
Indications |
Dose/Administration |
Possible Side effects |
Considerations |
Adenosine |
Antiarrhythmic |
SVT |
1st dose = 0.1 mg/kg rapid IV push to max of 6 mg |
Dizziness, headache, metallic taste, shortness of breath, hypotension, slow or fast heart rate, nausea, flushing, sweating |
Cardiac monitoring during administration; administer through central line if available; flush with saline following administration |
Amiodarone |
Antiarrhythmic |
SVT, VT with pulses, VF, VT without pulse |
SVT or VT with pulse: VF or VT without pulse: 5mg/kg rapid bolus to |
Headache, dizziness, tremors, syncope, hypotension, bradycardia, CHF, nausea, vomiting, diarrhea, rash, skin discoloration, hair loss, flushing, coagulation problems |
Monitor ECG and BP; use with caution in patients with a perfusing rhythm, hepatic failure; contraindicated for 2nd or 3rd degree heart block |
Atropine |
Anticholinergic |
Symptomatic bradycardia, toxins and overdoses |
Bradycardia: 0.02 mg/kg IV with 0.5 mg max dose may repeat one time Toxins/overdose: |
Headache, dizziness, confusion, anxiety, flushing, visual difficulties, pupil dilation, dry mouth, tachycardia, high or low blood pressure, nausea, vomiting, constipation, urinary retention, painful urination, rash, dry skin |
Monitor ECG, oxygen, and BP; administer before intubation if bradycardic; contraindicated in glaucoma and tachyarrhythmias |
Epinephrine |
Catecholamine vasopressor, Inotrope |
Anaphylaxis, asthma, symptomatic bradycardia, croup, shock, cardiac arrest, toxins or overdose |
Anaphylaxis: 0.01 mg/kg every 15 minutes to max of 0.3 mg Asthma: (1:1000) 0.01 mg/kg subcutaneous every 15 minutes to max 0.3 mg Symptomatic bradycardia: 0.01 mg/kg IV every 3-5 minutes to max dose of 1 mg Croup: 0.25 ml Racemic epi solution via nebulizer Cardiac arrest: 0.01 mg/kg (1:10000) IV or 0.1 mg/kg (1:1000) per ET tube every 3-5 minutes Shock: 0.1-1 mcg/kg/ minute IV infusion Toxins/ODs: 0.01 mg/kg (1:10000) IV to max dose of 1 mg |
Tremors, anxiety, headaches, dizziness, confusion, hallucinations, dyspnea, SVT, VT, palpitations, hypertension, nausea, vomiting, hyperglycemia, hypokalemia, vasoconstriction |
Available in 1:1000 and 1:10000 concentrations so the team must be aware of which concentration is being used; monitor BP, oxygen, and ECG; give via central line if possible; do not give in cocaine induced VT |
Oxygen |
Elemental gas |
Hypoxia, respiratory distress or failure, shock, trauma, cardiac arrest |
In resuscitation, administer at 100% via high flow system and titrate to response to maintain oxygen saturation >94% |
Headache, dry nose/ mouth, airway obstruction if secretions become dry |
Monitor oxygen saturation; insufficient flow rates may cause carbon dioxide retention |
Albumin |
Plasma volume expander |
Shock, trauma, burns |
0.5-1 g/kg by rapid infusion |
Fluid overload, increased respiratory rate, flushing, rash, hypocalcemia |
Use within 4 hours of opening vial |
Albuterol |
Bronchodilator |
Asthma, bronchospasm, hyperkalemia |
2.5 mg if weight <20 kg 5 mg if weight >20 kg |
Tremors, anxiety, headaches, bad taste, dry nose/throat, dyspnea, wheezing, tachycardia, hypotension, nausea, vomiting, flushing |
Should not be used with tachyarrhythmias |
Alprostadil |
Prostaglandin vasodilator |
Maintain patency of ductus arteriosus in congenital heart disease |
Initial: Maintenance: |
Apnea, bradycardia, vasodilation, hypotension, cardiac arrest, diarrhea, renal failure, flushing, fever, hypoglycemia, DIC, hypocalcemia, seizures |
May cause tissue sloughing, must not be bolused or stopped suddenly, should be refrigerated until administered |
Calcium chloride/gluconate |
Electrolyte |
Hypocalcemia, hyperkalemia; consider for calcium channel blocker overdose |
In cardiac arrest: 20 mg/kg IV bolus into central line In non-arrest: infuse over 30-60 minutes |
Hypotension, cardiac arrhythmias, cardiac arrest, burn or sclerosis of peripheral veins, hypercalcemia |
Monitor ECG and BP; contraindicated in digtoxicity or hypercalcemia; flush IV tubing before and after administration; do not administer with phosphorus-containing solutions |
Dexamethasone |
Corticosteroid |
Croup, asthma |
0.6 mg/kg for one dose (max dose 16 mg) |
Headache, insomnia, seizures, psychosis, visual difficulties, hypertension, edema, tachycardia, osteoporosis, diarrhea, nausea, GI bleeding, flushing, sweating, poor wound healing, hyperglycemia, sodium and fluid retention, hemorrhage, hypokalemia |
Can be given PO, IM or IV |
Dextrose |
Carbohydrate |
Hypoglycemia |
0.5-1 g/kg |
Sclerosis of veins, hyperglycemia |
Do not administer during resuscitation unless hypoglycemia is documented; use point of care glucose monitoring |
Diphenhydramine |
Antihistamine |
Anaphylaxis after epinephrine |
1-2 mg/kg every 4 to 6 hours to a max dose of 50 mg |
Dizziness, drowsiness, CNS symptoms, blurred vision, pupil dilation, dry nose/mouth/throat, hypotension, tachycardia, nausea, vomiting, urinary retention or frequency photosensitivity |
Monitor oxygen saturations and BP; use with caution in presence of glaucoma, ulcer, hyperthyroidism |
Dobutamine |
Beta-adrenergic |
Ventricular dysfunction |
2-20 mcg/kg/minute infusion |
Headache, dizziness, hypotension, palpitations, angina, nausea, vomiting thrombocytopenia |
Monitor ECG and BP; do not mix with sodium bicarbonate or alkaline solutions |
Dopamine |
Catecholamine vasopressor, inotrope |
Ventricular dysfunction, cardiogenic or distributive shock |
2-20 mcg/kg/minute infusion titrated to response |
Headache, dyspnea, palpitations, PVCs, SVT, VT, nausea, vomiting, acute renal failure |
Monitor ECG and BP; avoid high infusion rates; do not mix in alkaline solutions or with sodium bicarbonate |
Etomidate |
Short acting sedative with no analgesic properties |
Sedation for intubation or for patients with hypotension or multiple trauma |
0.2-0.4 mg/kg IV over 30 to 60 seconds with max dose of 20 mg |
Fast or slow respiratory rate, high or low blood pressure, tachycardia nausea, vomiting, cough |
Sedation will last |
Furosemide |
Loop diuretic |
Pulmonary edema, |
1 mg/kg IV or IM to max dose of 20 mg |
Headache, weakness, vertigo, hearing and vision problems, dry mouth, ECG changes, nausea, vomiting, diarrhea, abdominal cramping, polyuria, glycosuria, muscle cramps, sweating, hives, hyperglycemia, anemia, hypokalemia, hyponatremia, metabolic alkalosis |
Monitor BP, BUN, serum creatinine and electrolytes (especially potassium) |
Hydrocortisone |
Corticosteroid |
Adrenal insufficiency associated with septic shock |
2 mg/kg IV bolus to max dose of 100 mg |
Psychological signs, infections, blurred vision, hypertension, diarrhea, nausea, vomiting, osteoporosis, flushing, sweating, slow wound healing, hyperglycemia |
Watch for signs of infection |
Inamrinone |
Inotrope |
Myocardial dysfunction, cardiogenic shock, CHF |
Loading dose 0.75-1 mg/kg bolus over 5-10 minutes may repeat twice to max dose of 3mg/kg Infusion at 5-10 mcg/kg/minute |
Hypoxemia, hypotension, angina, arrhythmias nausea, vomiting, abdominal pain, jaundice, allergic reactions, thrombocytopenia |
Monitor ECG, oxygen, and BP |
Ipratropium |
Anticholinergic bronchodilator |
Asthma |
250-500 mcg every 20 minutes via nebulizer for 3 doses |
Anxiety, dizziness, headache, dry mouth, blurred vision, cough, bronchospasm, palpitations, nausea, vomiting, rash |
Monitor oxygen; if medication gets in eyes, will cause pupil dilation |
Lidocaine |
Antiarrhythmic |
VF, pulseless VT, wide complex tachycardia, RSI |
Tachyarrhythmias and VF: 1 mg/kg IV bolus followed by infusion of RSI: 1-2 mg/kg IV |
CNS symptoms, tinnitus, blurred vision, hypotension, heart block, bradycardia, cardiac arrest, dyspnea, respiratory depression, nausea, vomiting, rash |
Monitor ECG and BP; May cause seizures; contraindicated for wide complex bradycardia |
Magnesium sulfate |
Electrolyte, bronchodilator |
Asthma; torsades de pointes; hypo-magnesemia |
Asthma: 25-50 mg/kg over 15-30 minutes IV Pulseless torsades: VT with pulses and torsades: 25-50 mg/kg over 10-20 minutes |
Confusion, sedation, weakness, respiratory depression, hypotension, heart block, bradycardia, cardiac arrest, nausea, vomiting, muscle cramps, flushing, sweating |
Monitor ECG, oxygen and BP; rapid bolus may cause hypotension and bradycardia; calcium chloride can be used if needed to reverse hypermagnesemia |
Methylprednisolone |
Corticosteroid |
Asthma, anaphylactic shock |
2 mg/kg to max of 60 mg IV as loading dose; |
Depression, headache, weakness, hypertension, diarrhea, nausea, pancreatitis, ulcer, osteoporosis, hyperglycemia |
Watch for rare anaphylaxis |
Milrinone |
Inotrope, vasodilator |
Cardiogenic shock or post-surgery CHF |
50 mcg/kg IV over 10-60 minutes as loading dose |
Headache, tremor, hypotension, ventricular arrhythmias, angina, nausea, vomiting, jaundice, hypokalemia |
Monitor ECG, BP and platelet count; hypovolemia may make hypotension worse; use longer infusion time |
Naloxone |
Opioid antagonist |
Narcotic reversal |
For total reversal: |
Seizures, drowsiness, rapid respiratory rate, pulmonary edema, VF, VT, tachycardia, asystole, hypertension nausea, vomiting |
Monitor ECG, oxygen and BP; repeat doses often needed; establish assisted ventilation before administration; monitor newborn of addicted mother |
Nitroglycerine |
Vasodilator, antihypertensive |
CHF, cardiogenic shock |
Begin infusion at 0.25-0.5 mcg/kg/minute and titrate every 15-20 minutes to max dose of 10 mcg/kg/minute |
Headache, dizziness, hypoxemia, hypotension, cardiac arrest, tachycardia, flushing, pallor |
Monitor ECG and BP; watch for hypotension in hypovolemic children |
Nitroprusside |
Vasodilator antihypertensive |
Cardiogenic shock Hypertension |
0.3-1 mcg/kg/minute for initial dose then titrate to max 8 mcg/kg/minute |
Seizures, dizziness, headache, agitation, hypotension, slow or fast heart rate, nausea, vomiting |
Monitor ECG and BP; if used for prolonged times; thiocyanate and cyanide levels should be monitored |
Norepinephrine |
Inotrope vasopressor |
Hypotensive shock |
0.1-2 mcg/kg/minute titrated to desired BP |
Headache respiratory distress hypertension arrhythmias renal failure |
Monitor ECG and BP; IV infiltration may lead to tissue necrosis; should be administered via central line; do not mix in alkaline solution |
Procainamide |
Antiarrhythmic |
SVT, atrial flutter, VT with pulse |
15 mg/kg as loading dose over 30-60 minutes |
Headache, dizziness, confusion, weakness, hypotension, prolonged QT interval, heart blocks and cardiac arrest, nausea, vomiting, diarrhea, rash, edema, anemia, neutropenia |
Monitor ECG (particularly QT interval) and BP; expert consultation should be called before administration |
Sodium bicarbonate |
Electrolyte to produce alkalinity |
Severe metabolic acidosis, hyperkalemia, tricyclic overdose |
1 mEq/kg slow IV bolus to max of 50 mEq For overdose 1-2 mEq/kg bolus repeating until pH >7.45 follow with infusion of sodium bicarb solution to maintain alkalosis |
CNS symptoms, arrhythmia, hypotension, cardiac arrest, renal calculi, cyanosis, edema, metabolic alkalosis and other derangements, water retention |
Monitor ECG, oxygen and ABGs; ensure adequate ventilatory support to reduce the chance of carbon dioxide accumulation; not recommended in cardiac arrest |
Terbutaline |
Bronchodilator, beta adrenergic agonist |
Asthma, hyperkalemia |
0.1-10 mcg/kg/ minute IV Infusion 10 mcg/kg SQ every 10-15 minutes until IV is established |
CNS symptoms, palpitations, tachycardia, nausea, vomiting, arrhythmias, hypotension |
Monitor ECG, oxygen and BP; use cautiously in children with hypokalemia |
Vasopressin |
Antidiuretic hormone analogue |
Cardiac arrest, septic shock |
0.4-1 unit/kg bolus to max of 40 units |
Fever, vertigo, dysrhythmias, hypertension, nausea, vomiting, abdominal cramps, urticaria |
Monitor BP and distal pulses; watch for signs of water intoxication; tissue necrosis may develop from IV extravasation |